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Abstract
Rationale Reduced brain serotonin function is acknowledged
as a vulnerability factor for affective disturbances. Since the
production of serotonin is limited by the availability of its
plasma dietary amino acid precursor tryptophan (TRP), the
beneficial effects of tryptophan-rich alpha-lactalbumin whey
protein (ALAC) have recently been studied. The effects of
ALAC remain rather modest, and alternative protein sources
of tryptophan may be more effective.
Objectives We tested whether hydrolyzed protein (HPROT)
has greater effects on the plasma TRP/large neutral amino
acids (LNAA) ratio and mood than intact ALAC protein in
healthy volunteers.
Materials and methods In a double-blind, randomized
cross-over study, plasma amino acids and mood were
repeatedly measured in 18 healthy subjects before and after
intake of ALAC and HPROT as well as after placebo
protein, pure tryptophan, and a tryptophan-containing
synthetic peptide. Except for the placebo protein, all
interventions contained 0.8 g TRP.
Results Significantly faster and greater increases in plasma
TRP/LNAA were found after HPROT than after ALAC. In
addition, the effects of HPROT on plasma TRP/LNAAwere
comparable with the effects of the tryptophan-containing
synthetic peptide and even exceeded the effect of pure
tryptophan. Sixty minutes after intake, mood was improved
only following intake of HPROT and pure tryptophan,
whereas longer-lasting mood effects were only found after
intake of HPROT.
Conclusions The use of a tryptophan-rich hydrolyzed
protein source may be more adequate to increase brain
tryptophan and 5-HT function compared with intact alpha-
lactalbumin protein or pure tryptophan.
Keywords Tryptophan . Serotonin . Protein . Hydrolysate .
Alpha-lactalbumin . Amino acids .Mood
Introduction
Brain serotonin (5-HT) receptors are widely distributed in
the central nervous system and involve the regulation of
several essential behavioral and physiological functions
(e.g., mood, sleep, appetite, sexual behavior). Reduced 5-
HT function is particularly recognized as a vulnerability
factor involved in affective disorders, whereas increases in
brain 5-HT are found to improve mood and to reduce
affective disturbances in healthy and (sub)clinical subjects
(Maes and Meltzer 1995; Markus 2003; Markus et al. 1999;
Van Praag 2004).
Since 5-HT is synthesized from the essential amino acid
tryptophan (TRP), dietary manipulation of plasma TRP has
been developed as a method to influence brain 5-HT
synthesis. A significant increase in brain tryptophan and
5-HT can be accomplished by the intake of pure tryptophan,
by increasing carbohydrate intake, or by consumption of
tryptophan-rich alpha-lactalbumin protein. These manipu-
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lations increase plasma concentrations of tryptophan to the
sum of the other large neutral amino acids (TRP/LNAA
ratio) and give tryptophan the advantage in competition for
access into the brain (Curzon 1985; Fernstrom et al. 1973;
Fernstrom and Wurtman 1971). These dietary effects on the
plasma TRP/LNAA ratio have been demonstrated frequently
(Lieberman et al. 1986; Markus 2007; Markus et al. 1998;
Rosenthal et al. 1989) and clear associations have been
found between plasma TRP/LNAA and brain 5-HT in
animal as well as human studies after tryptophan depletion
(Biggio et al. 1974; Carpenter et al. 1998; Nishizawa et al.
1997; Williams et al. 1999) and tryptophan challenge
(Fernstrom and Wurtman 1971; Markus et al. 2000; Orosco
et al. 2004).
Although these dietary methods may seem to be useful
to improve 5-HT-related affective functioning by increasing
brain 5-HT, their effects seem to be rather modest. Hence, a
20–25% increase in plasma TRP/LNAA as found with
carbohydrate-rich diets does not seem to be sufficient
enough to initiate meaningful behavioral changes (Markus
et al. 1999; Markus et al. 1998). In addition, only modest
effects of carbohydrates on mood are almost exclusively
found in affected or subclinical subjects, whereas these
effects are rather inconsistent or missing in healthy subjects
(Markus 2003).
Supplementing food with pure tryptophan is in many
cases limited by regulatory restrictions. However, the use of
alpha-lactalbumin (ALAC) was recently introduced as a
dietary method to further increase brain 5-HT and improve
cognitive–affective behavior. ALAC is a whey-derived
protein that contains a higher tryptophan content than most
food protein sources (Heine et al. 1996). Recent studies
reveal 50–130% increases in plasma TRP/LNAA after
ALAC intake (Booij et al. 2006; Markus et al. 2005;
Markus et al. 2000; Merens et al. 2005; Orosco et al. 2004;
Scrutton et al. 2007). This TRP/LNAA increase improves
brain 5-HT function (Markus et al. 2000; Orosco et al.
2004) and mood- or stress-related affective behavior
(Markus et al. 2000). It even reduces sleep disturbances in
rats (Minet-Ringuet et al. 2004) and causes sleep-related
improvement in behavioral and brain measures of concen-
tration in human subjects (Markus et al. 2005). Using
ALAC has a clear nutritional advantage over pure trypto-
phan and carbohydrates and can also be given for a longer
period of time through daily consumption. Nevertheless,
the beneficial effects of ALAC on cognitive–affective
behavior remain to be rather modest and are not always
clearly found (Merens et al. 2005). It may be that the
increase in plasma TRP/LNAA by ALAC is too small to
cause meaningful behavioral changes. Instead of using
intact ALAC protein, hydrolyzed protein with a TRP/
LNAA ratio superior to ALAC or other food sources of
TRP may lead to faster and greater increases in plasma
TRP/LNAA and may, therefore, also cause faster and
stronger increases in brain 5-HT and affective changes.
The aim of the present study was to investigate the
effects on plasma TRP/LNAA ratio and mood after
consumption of hydrolyzed protein (HPROT) compared to
other sources of tryptophan by healthy volunteers. During
five experimental sessions, plasma amino acid concentrations
were measured before and several times after intake of intact
ALAC, HPROT, and placebo protein, as well as after pure
tryptophan and a tryptophan-containing synthetic peptide as
positive controls. In addition, mood was measured before
and after intake. All of the interventions (except the placebo)
contained similar amounts of TRP, but differed in their
content of other amino acids.
Materials and methods
Subjects
Eighteen healthy students (nine men and nine women aged
between 18 and 30 years) at Maastricht University
participated in the study. Exclusion criteria for participation
were chronic and current illness; history of psychiatric or
medical illness; medication use; metabolic, hormonal, or
intestinal diseases; irregular diets or deviant eating habits;
excessive use of alcohol (>2 U/day), cigarettes, coffee, and/
or drugs; aversion for sugar-rich products; pregnancy; and
any discomfort with blood drawing procedures as assessed
by health and lifestyle questionnaires. Subjects participating
in the experiment had a body mass index in the normal
range (BMI in kg/m2 between 20 and 25), and female
subjects were matched for contraception. Women partici-
pated during their mid–late follicular phase (day 4–10),
while women using contraception participated when they
actually used the contraception pill. All subjects that
participated in the experiment were nonsmokers and
nondrug users and were not allowed to drink alcohol
starting 2 days before the experiment until the end of the
experiment. The study was approved by the Medical Ethics
Committee (MEC 06-3-029) of the Academic Hospital
Maastricht (Maastricht, The Netherlands), and the procedures
followed were in accordance with the Helsinki Declaration of
1975 as revised in 1983. All subjects gave their signed
informed consent to participate in the experiment prior to their
inclusion in the experiment and received a financial compen-
sation for their participation.
Procedure
Approximately 600 students at Maastricht University
received written information about the study and an
invitation to participate. In addition, students who were
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interested to participate were requested to complete and
return a questionnaire package concerning general informa-
tion (health, smoking and drinking habits, caffeine consump-
tion, weight and height, and use of psychoactive drugs) and
several questionnaires concerning psychopathology (mood
disorders, family history of depression, medical complaints,
etc.). From the subjects showing interest in taking part in
the experiment, 18 healthy subjects were selected for the
experiment. Subsequently, subjects taking part in the
experiment were invited at the laboratory to receive
information about the study and to become familiar with
the environment and experimental procedures.
During five experimental morning sessions, subjects
visited the laboratory to monitor plasma TRP/LNAA
concentrations and mood following intake of a drink
containing different TRP/LNAA ratios (see the “Diets”
section). The order of presentation of dietary conditions
was counterbalanced, and the five experimental days were
separated by a 1-week period. Before and 15, 30, 60, 90
120, 180, and 210 min after ingestion, blood samples were
taken to measure the dose-dependent effect (response
curve) of the different tryptophan or protein sources on
plasma amino acid concentrations and the TRP/LNAA
ratio. In addition, mood was measured before, 60 min, and
210 min after intake (Fig. 1).
On each experimental morning, six subjects arrived at
the laboratory at 8:30 A.M. Subjects had been instructed to
fast overnight; only water or tea without sugar was
permitted. In addition, subjects were not allowed to use
any kind of drugs before and during the experiment (see
selection criteria) or to drink alcohol the day before their
participation and arrival at the laboratory. After arrival,
subjects were allowed to rest for a while before an
indwelling catheter was inserted in their nonpreferred
forearm. Then all subjects were brought into a laboratory
room containing sitting areas with separated computer
systems. Each subject was separately seated in front of his
or her personal computer screen and instructed about the
experiment. Subsequently, subjects were exposed to a
computerized version of the profile of mood state (POMS)
(for detailed description, see below). After the first test
session, subjects received a test drink containing different
TRP/LNAA ratios. Before, 60 min, and 210 min after
intake, respectively, a first, second, and third mood measure
was conducted. Before and 15, 30, 60, 90 120, 180, and
210 min after intake, blood samples were taken to measure
the dietary effects on plasma amino acid concentrations.
Between measurements, all subjects stayed in the laboratory
room to read or work on their own private computer.
Diets
On each experimental morning, a 312-ml drink was
consumed containing different tryptophan (TRP) or LNAA
concentrations. The reference condition included 20 g
casein protein (PLC: DSM, Delft, The Netherlands) with
0.4 g TRP and 10 g LNAA, whereas the test conditions
included 15 g intact alpha-lactalbumin (ALAC) whey
protein (BioPURE, Davisco Foods International, USA)
with 0.8 g TRP and 9.4 g LNAA, protein hydrolysate or
HPROT (PeptoBalance™: DSM, Delft, The Netherlands)
with 0.8 g TRP and 4 g LNAA, 0.8 g pure tryptophan
N=18
Session 1 Session 2
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Fig. 1 General design (a) and time schedule (a) of the experiment. a
During five experimental sessions, 18 subjects received protein and
peptide sources with different TRP and LNAA concentrations. Order
of treatment was balanced between three groups. b During each
experimental session, subjects received the protein or peptide source
after a baseline mood and blood measure. Before, 60 min, and
210 min after intake, mood was measured. Before and 30, 60, 90, 120,
180, and 210 min after intake, plasma samples were taken for amino
acid assessment
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(TRP: Orthica, Almere, The Netherlands) and 1.2 g
synthetic peptide (SYN: Ser–TRP, DSM, Delft; Molecular
formula C14H17N3O4) containing 0.8 g tryptophan (Tables 1
and 2).
All drinks are prepared by mixing the powder with
0.10 g sweetener (acesulfame) and were filled up by plain
water in order to reach a 312-ml drink. Research assistants
blind to the dietary conditions conducted the administration
of the different drinks.
Measurements
Profile of mood states
Changes in mood are measured using a computerized
Dutch shortened version of the POMS questionnaire (Wald
and Mellenbergh 1990) as a visual analogue scale ranging
from “strongly disagree” to “strongly agree.” The POMS
was calculated by the total mood scores on five different
subscales, ranging from anger, depression, fatigue, and
tension that refer to a negative mood state to vigor
concerning a positive mood.
Biochemical analyses
Blood samples were collected in duplicate in 5 ml
vacutainer tubes containing sodium heparin and centrifuged
at 5,000 rpm for 5 min at 4°C. Subsequently, the super-
natants were directly stored at −80°C until analysis. Before
storage, the supernatant (100 μl) was mixed with 4 mg
sulfasalicyl acid. Plasma amino acid analysis was con-
ducted with high-pressure liquid chromatography (HPLC),
making use of a 2- to 3-μm Bischof Spherisorb ODS II
column. The plasma tryptophan ratio was calculated by
dividing the plasma tryptophan concentration (in μmol/L)
by the sum of the other large neutral amino acids, i.e.,
valine, isoleucine, leucine, tyrosine, and phenylalanine.
Experimental design and statistical analysis
The main research questions formulated in the introduction
were analyzed by means of repeated-measures multivariate
and univariate analyses of variance (MANOVA and
ANOVA) by using the general linear model (GLM; SPSS
12.0 for Windows) with one within-subjects factors
“condition” (five different conditions: PLC, ALAC,
HPROT, TRP, SYN) on the several dependent measures
from mood and plasma amino acids. Although we already
counterbalanced for order of condition, this variable was
preliminarily taken as a between-subjects factor. Yet,
because order of intervention did not contribute to any of
the results, final analyses were performed with only
condition as a within-subjects factor. For the effect of
diet manipulation on blood samples, repeated-measures
MANOVA was performed with first- and second-order
polynomial contrasts. Only significant results revealed by
these procedures were further examined by univariate tests.
Huynh–Feldt or Greenhouse–Geisser corrected P values,
their corresponding epsilons, as well as the original, i.e.,
uncorrected, degrees of freedom are reported when the
sphericity assumption was not met. The study, including
validation of the group size, was designed to detect a large
effect size (μ2 0.20) for a power of 0.80 at alpha=0.05
(requiring a group size of at least 17 subjects). All statistics
were evaluated at a significance level of 5%. Data are
reported as the means±SD.
Results
Plasma TRP/LNAA
A first repeated-measures ANOVA with condition (PLC,
ALAC, HPROT, TRP, SYN) and time (0, 30, 60, 90, 120,
180, and 210 min) as within-subjects factors on the plasma
TRP/LNAA ratio revealed a main significant effect of time
[F(6,90)=122; P<0.0001] and condition [F(4,60)=79,68;
P<0.0001] and a significant interaction between condition
and time [F(24,360)=41,50; P<0.0001], indicating that the
Table 2 Amino acid profile
Amino acid profile (g) HPROT PLC ALAC
Isoleucine 1.004 1.800 2.012
Leucine 0.745 2.733 3.306
Phenylalanine 0.480 1.467 1.309
Tyrosine 1.216 1.867 1.451
Valine 0.554 2.133 1.322
Tryptophan 0.8 0.4 0.8
Total 3.999 10 9.4
Table 1 Composition of the standard protein (PLC), alpha-lactalbumin
whey protein (ALAC), protein hydrolysate (HPROT), pure tryptophan
(TRP), and synthetic dipeptide (SYN) condition
Source Product (g) TRP (g) TRP/LNAA
(mol/mol)
PLC 20 g/312 ml 0.4 0.04
ALAC 15 g/312 ml 0.8 0.1
HPROT 312 ml 0.8 1.1
TRP 0.8 g/312 ml 0.8 ∞
SYN 1.2 g/312 ml 0.8 ∞
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increase in plasma TRP/LNAA ratio across time differed
between conditions. As shown in Fig. 2, the highest
significant increases in plasma TRP/LNAA ratio were
found 30–120 min after SYN [F(6,96)=87,89; P<0.0001]
and HPROT [F(6,90)=86,54; P<0.0001]. There were no
significant differences in peak TRP/LNAA responses
between these two conditions with the exception that peak
(263%) increases in TRP/LNAA after SYN appeared
significantly faster (after 60 min) than peak (255%)
increases after HPROT (after 90 min) [F(3,14)=3,66;
P=0.04]. The increase in TRP/LNAA after HPROT and
SYN was significantly faster and higher than after TRP
[F(4,60)=4,56; P=0.003]. With TRP, a peak 191% increase
in TRP/LNAAwas found 120 min after intake (P<0.0001).
A significant increase in plasma TRP/LNAA was also
found 60–210 min after ALAC [F(6,96)=72; P<0.0001]
with a peak 67% increase 120 min after intake (P<0.0001),
but this was significantly lower compared with HPROT
[F(4,60)=60,4; P<0.0001] and TRP [F(4,64)=30,83;
P<0.0001]. After PLC, there was a significant decline in
TRP/LNAA starting 60 min (−27%) until 210 min (<0.001)
after intake [F(6,96)=32,95; P<0.0001]. The amino acid
concentrations of the different protein and peptide sources
across time are given in Table 3 and the plasma TRP/
LNAA ratios of different conditions across time are given
in Table 4.
Mood
Repeated-measures ANOVA with condition (PLC, ALAC,
HPROT, TRP, SYN) and time (0, 60, and 210 min) as
within-subjects factors on the total mood scores revealed a
significant effect of time [F(2,32)=3,27; P<0.05] and a
significant interaction of condition×time [F(4,64)=3,68;
P=0.009], indicating that mood changes across time
significantly differed between conditions. As shown in
Fig. 3, comparable improvements of mood were found
60 min after HPROT (P=0.015) and TRP (P=0.010) but
only after HPROT mood further improved 210 min after
intake compared with TRP (P=0.04). In contrast, no mood
changes were found after PLC (P>0.2) and ALAC
(P=0.2). Although mood also seem to improve after SYN,
this was not significant (P>0.2).
Conclusion
The aim of the present study was to investigate whether a
protein hydrolysate (HPROT) has a greater effect on
temporal increases in plasma TRP/LNAA and mood
compared with intact alpha-lactalbumin (ALAC) protein
in healthy volunteers. In addition, a tryptophan-containing
synthetic peptide (SYN) and pure tryptophan (TRP) were
included as positive controls. Significantly faster and
greater increases in plasma TRP/LNAA where found after
HPROT intake than after intake of ALAC. In addition, the
effects of HPROT on plasma TRP/LNAA were comparable
with the effects of the tryptophan-containing synthetic
dipeptide and even exceeded the effect of pure tryptophan
(TRP). Mood improved after HPROT and TRP 60 min after
intake, and the most profound and durable mood improving
effects were found with HPROT 210 min after intake.
Effects on plasma TRP/LNAA
In general, the changes of the TRP/LNAA ratios were
consistent with the kinetics of TRP concentrations reported
earlier (Domino 1976; Yuwiler et al. 1981). There was a
significantly greater increase in plasma TRP/LNAA after
intake of the protein hydrolysate HPROT (255%) compared
with intact whey protein ALAC (67%). This effect of
HPROT on plasma TRP/LNAA was comparable with the
tryptophan-containing synthetic peptide (SYN) and even
largely exceeded the 191% increase in plasma TRP/LNAA
induced by pure tryptophan. Since all sources (except the
negative control) contained equal amounts of TRP, it was
anticipated that the differences found in plasma TRP/
LNAA ratios should be due primarily to differences in
LNAA content between the sources. Whereas this notion is


























Fig. 2 Mean changes in plasma tryptophan compared with the other
large neutral amino acids ratio (TRP/LNAA) after intake of hydrolyzed
protein (HPROT), alpha-lactalbumin (ALAC), casein protein (PLC),
pure tryptophan (TRP), and tryptophan-containing synthetic peptide
(SYN). A multivariate significant interaction of condition by time
[P<0.0001] revealed the highest and fastest significant increases in
plasma TRP/LNAA ratio 30–120 min after SYN [P<0.0001] and
HPROT [P<0.0001]
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the findings on pure TRP and the synthetic dipeptide show
that other factors may play a role as well. Both pure TRP
and SYN have an infinitely high TRP/LNAA ratio, but
synthetic dipeptide results in a substantially higher plasma
TRP/LNAA ratio than pure TRP. We speculate that TRP in
the form of small peptides has a better bioavailability than
pure TRP as such. It has been suggested that a 40–70%
variation in plasma TRP/LNAA could be sufficient to
change brain 5-HT content in animal as well as human,
either reducing brain 5-HT by lowering plasma TRP/LNAA
after tryptophan depletion (Biggio et al. 1974; Carpenter
et al. 1998; Nishizawa et al. 1997; Williams et al. 1999) and
Table 3 Plasma amino acid concentrations (μm/L) across time after protein (PLC), alpha-lactalbumin protein (ALAC), protein hydrolysate
(HPROT), pure tryptophan (TRP), and synthetic dipeptide (SYN)
Amino acid Condition Time (min)
0 30 60 90 120 180 210
Isoleucine PLC 0.07 0.10 0.18 0.15 0.12 0.09 0.08
ALAC 0.08 0.12 0.20 0.22 0.18 0.12 0.11
HPROT 0.07 0.09 0.09 0.14 0.09 0.08 0.09
TRP 0.07 0.07 0.07 0.06 0.07 0.07 0.07
SYN 0.06 0.07 0.06 0.06 0.06 0.06 0.07
Leucine PLC 0.12 0.19 0.31 0.26 0.22 0.17 0.16
ALAC 0.13 0.22 0.37 0.38 0.28 0.21 0.20
HPROT 0.13 0.14 0.14 0.13 0.13 0.13 0.14
TRP 0.13 0.13 0.12 0.12 0.12 0.12 0.13
SYN 0.11 0.14 0.12 0.12 0.12 0.12 0.13
Phenylalanine PLC 0.06 0.08 0.10 0.08 0.08 0.06 0.06
ALAC 0.07 0.09 0.11 0.10 0.09 0.07 0.07
HPROT 0.07 0.07 0.07 0.06 0.10 0.06 0.07
TRP 0.07 0.07 0.06 0.06 0.06 0.06 0.06
SYN 0.06 0.07 0.06 0.06 0.06 0.06 0.06
Tyrosine PLC 0.06 0.07 0.12 0.11 0.09 0.07 0.07
ALAC 0.06 0.08 0.12 0.12 0.10 0.08 0.08
HPROT 0.06 0.07 0.07 0.06 0.06 0.06 0.06
TRP 0.06 0.06 0.06 0.05 0.06 0.05 0.05
SYN 0.05 0.06 0.05 0.05 0.05 0.05 0.05
Valine PLC 0.24 0.28 0.45 0.42 0.38 0.32 0.30
ALAC 0.26 0.30 0.38 0.42 0.35 0.29 0.28
HPROT 0.26 0.27 0.25 0.25 0.25 0.25 0.26
TRP 0.25 0.25 0.23 0.22 0.23 0.22 0.23
SYN 0.21 0.26 0.22 0.22 0.22 0.21 0.23
Tryptophan PLC 0.06 0.07 0.08 0.08 0.07 0.06 0.05
ALAC 0.07 0.09 0.18 0.23 0.19 0.13 0.12
HPROT 0.07 0.13 0.21 0.23 0.20 0.14 0.13
TRP 0.07 0.07 0.17 0.18 0.18 0.13 0.11
SYN 0.06 0.13 0.21 0.18 0.15 0.11 0.10
Table 4 Plasma TRP/LNAA ratios (μm/L) across time after protein (PLC), alpha-lactalbumin protein (ALAC), protein hydrolysate (HPROT),
pure tryptophan (TRP), and synthetic dipeptide (SYN)
Plasma ratio Condition Time (min)
0 30 60 90 120 180 210
TRP/LNAA PLC 0.11 0.09 0.08 0.08 0.08 0.08 0.08
ALAC 0.12 0.12 0.15 0.18 0.2 0.18 0.17
HPROT 0.11 0.19 0.36 0.39 0.35 0.25 0.22
TRP 0.11 0.12 0.29 0.31 0.32 0.24 0.20
SYN 0.11 0.22 0.40 0.37 0.31 0.22 0.19
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increasing 5-HT by enhancing plasma TRP/LNAA after
tryptophan challenge (Fernstrom and Wurtman 1971;
Markus et al. 2000; Orosco et al. 2004) or increasing
carbohydrates in normal meals (Wurtman et al. 2003).
Since the current 255% rise in TRP/LNAA induced by
consumption of hydrolyzed protein (HPROT) largely
exceeds this threshold and also based on findings that
tryptophan suppletion affected mood and behavior in
human (Markus et al. 2000; for review, see Markus 2008),
it is very likely that this causes a much greater rise in
available brain TRP and 5-HT and a subsequent stronger
psychological–emotional effect in the brain.
A significant improvement in mood was found 1 h after
consumption of the protein hydrolysate (HPROT) and
intake of pure L-tryptophan. Moreover, only HPROT was
able to induce a sustained mood improvement until 210 min
after intake. No significant effects were found with intact
whey protein (ALAC) or the synthetic tryptophan dipep-
tide. The absence of a mood effect after consumption of
ALAC is comparable with previous studies, showing that
ALAC only induces beneficial effects on mood in stress-
vulnerable subjects under acute stress exposure (Markus
2003; Markus et al. 2000). Current results suggest that a
large 255% increase in plasma TRP/LNAA may be
sufficient to improve baseline mood in nonvulnerable
subjects as well. Nevertheless, the effects of HPROT may
still be more profound in serotonin-vulnerably subjects and/
or when brain tryptophan supply is actually required.
People differ in their sensitivity to alterations in the
serotonergic system, and among the different factors
involved in such brain serotonin vulnerabilities, genetic
proneness and chronically stressful circumstances are the
most frequently described (Firk and Markus 2007; Jans
et al. 2007; Markus 2003; Markus et al. 2000). Thus, most
beneficial effects of brain tryptophan supply may be
expected in “serotonin-vulnerable” subjects like people
with a family history of depression, carrying the susceptible
short-allele serotonin transporter gene (5-HTTLPR), in
chronically stressed subjects (Firk and Markus 2007; Jans
et al. 2007; Markus 2003; Markus et al. 2000), or in
clinically depressed or remitted subjects who respond to
selective serotonin reuptake inhibitors. This intriguing
hypothesis certainly deserves further investigation.
Contrary to our expectations, there were no significant
improvements in mood after intake of a tryptophan-
containing synthetic peptide (SYN). Although mood tended
to be improved after SYN compared with PLC and ALAC,
this effect was not statistically significant. This is surprising
since the increase in plasma TRP/LNAA following intake
of SYN was comparable to the increase found after
consumption of HPROT and even exceeded the 191%
increase in plasma TRP/LNAA as found after pure
tryptophan. Although hypothetically, it may be that the
brain bioavailability of tryptophan released from a synthetic
dipeptide is somehow reduced. Alternatively, the power of
the current study may not have been sufficient to detect a
significant difference in the SYN condition.
Current findings support the assumption that the use of a
hydrolyzed protein may be a more adequate method to
increase central tryptophan and serotonin levels and brain
function compared to intact alpha-lactalbumin or pure
tryptophan and, hence, to further improve serotonin-related
affective behavior. Although the beneficial affective effects
of tryptophan supply appear to be rather negligible in
healthy subjects under normal circumstances, it is anticipated
that the effects of the current hydrolyzed protein may become
more vivid when chronically administered, under high
affecting circumstances that require enhanced tryptophan
supply, and in clinically or serotonin-vulnerable subjects
who are responsive to brain serotonin manipulations. This
should be explored in future research.
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Fig. 3 Mean differences in the total mood changes of the POMS after
intake of hydrolyzed protein (HPROT), alpha-lactalbumin (ALAC),
casein protein (PLC), pure tryptophan (TRP), and tryptophan-containing
synthetic peptide (SYN). A significant interaction of condition by time
[P=0.009] indicated comparable mood improvements 60 min after
HPROT (P=015) and TRP (P=0.010) with the most durable mood
improvements following HPROT 210 min after intake (P=0.04)
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